FF
LLY icon

Farrow Financial’s Eli Lilly LLY Stock Holding History

Farrow Financial’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.62M Sell
2,184
-320
-13% -$327K 1.4% 30
2026
Q1 		$2.3M Sell
2,504
-91
-4% -$92.3K 1.31% 34
2025
Q4 		$2.79M Buy
2,595
+8
+0.3% +$7.65K 1.6% 23
2025
Q3 		$1.97M Buy
2,587
+6
+0.2% +$4.46K 1.15% 33
2025
Q2 		$2.01M Sell
2,581
-93
-3% -$72.3K 1.22% 35
2025
Q1 		$2.21M Buy
2,674
+21
+0.8% +$17.5K 1.49% 30
2024
Q4 		$2.05M Buy
2,653
+207
+8% +$171K 1.33% 31
2024
Q3 		$2.17M Sell
2,446
-23
-0.9% -$20.7K 1.37% 32
2024
Q2 		$2.24M Buy
2,469
+17
+0.7% +$13.6K 1.52% 21
2024
Q1 		$1.91M Buy
2,452
+30
+1% +$21.4K 1.34% 33
2023
Q4 		$1.41M Buy
+2,422
New +$1.41M 1.06% 37

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Farrow Financial's LLY Position: Q2 2026 in Review

Farrow Financial reduced its Eli Lilly (LLY) stake by 13% in Q2 2026, selling an estimated $327K and leaving 2,184 shares worth $2.62M. The position accounts for 1.4% of the portfolio, ranked #30.

Farrow Financial first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.79M in Q4 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Farrow Financial held 2,184 shares of Eli Lilly worth $2.62M as of Q2 2026.
  • Farrow Financial sold 320 Eli Lilly shares in Q2 2026, an estimated $327K.
  • Eli Lilly made up 1.4% of Farrow Financial's portfolio in Q2 2026, its #30 holding.
  • Farrow Financial first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • Farrow Financial's Eli Lilly position peaked at $2.79M in Q4 2025.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Farrow Financial's 13F filing for Q2 2026, filed 4 Aug 2026.